Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
ReShape Lifesciences Inc. (RSLS) had Normalized Income after Taxes of $-7.13M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$8.01M |
|
$-7.13M |
|
$2.95M |
|
$5.06M |
|
$15.73M |
|
$-7.73M |
|
$0.64M |
|
$-7.09M |
|
$-7.09M |
|
$-7.13M |
|
$-7.13M |
|
$-7.13M |
|
|
Normalized Income after Taxes |
$-7.13M |
$-7.73M |
|
$-7.60M |
|
0.02M |
|
0.02M |
|
$-345.75 |
|
$-345.75 |
|
| Balance Sheet Financials | |
$4.59M |
|
$0.04M |
|
$0.20M |
|
$4.79M |
|
$4.99M |
|
-- |
|
$0.06M |
|
$5.05M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
0.03M |
|
| Cash Flow Statement Financials | |
$-4.43M |
|
-- |
|
$0.68M |
|
$4.56M |
|
$0.79M |
|
$-3.77M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.92 |
|
-- |
|
-- |
|
-- |
|
-3.21 |
|
63.17% |
|
-96.53% |
|
-96.53% |
|
-94.97% |
|
-88.57% |
|
-89.06% |
|
$-4.43M |
|
-- |
|
-- |
|
-- |
|
1.67 |
|
1.20 |
|
8.11 |
|
45.00 |
|
2818.33% |
|
2818.18% |
|
-148.76% |
|
2818.18% |
|
$-8.66 |
|
$-214.49 |
|
$-214.49 |
|